These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

116 related articles for article (PubMed ID: 34431881)

  • 21. CHOROIDAL THICKNESS AS A PROGNOSTIC FACTOR OF PHOTODYNAMIC THERAPY WITH AFLIBERCEPT OR RANIBIZUMAB FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Sakurada Y; Sugiyama A; Tanabe N; Kikushima W; Kume A; Iijima H
    Retina; 2017 Oct; 37(10):1866-1872. PubMed ID: 28002268
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Subretinal hemorrhage from a peripapillary choroidal neovascular membrane in papilledema caused by idiopathic intracranial hypertension.
    Sathornsumetee B; Webb A; Hill DL; Newman NJ; Biousse V
    J Neuroophthalmol; 2006 Sep; 26(3):197-9. PubMed ID: 16966941
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Switching to intravitreal aflibercept injection for polypoidal choroidal vasculopathy refractory to ranibizumab.
    Saito M; Kano M; Itagaki K; Oguchi Y; Sekiryu T
    Retina; 2014 Nov; 34(11):2192-201. PubMed ID: 25077530
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Correlation of indocyanine green angiography and optical coherence tomography findings after intravitreal ranibizumab for polypoidal choroidal vasculopathy.
    Ueno C; Gomi F; Sawa M; Nishida K
    Retina; 2012; 32(10):2006-13. PubMed ID: 22772392
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Efficacy of intravitreal bevacizumab combined with photodynamic therapy for polypoidal choroidal vasculopathy.
    Gomi F; Sawa M; Wakabayashi T; Sasamoto Y; Suzuki M; Tsujikawa M
    Am J Ophthalmol; 2010 Jul; 150(1):48-54.e1. PubMed ID: 20609707
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Intravitreal ranibizumab for polypoidal choroidal vasculopathy with recurrent or residual exudation.
    Saito M; Iida T; Kano M
    Retina; 2011 Sep; 31(8):1589-97. PubMed ID: 21654347
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Peripapillary neovascular membrane: a rare cause of acute vision loss in pediatric idiopathic intracranial hypertension.
    Kaeser PF; Borruat FX
    J AAPOS; 2011 Feb; 15(1):83-6. PubMed ID: 21397812
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Efficacy of combined photodynamic therapy and intravitreal bevacizumab injection versus photodynamic therapy alone in polypoidal choroidal vasculopathy.
    Kim SJ; Yu HG
    Retina; 2011 Oct; 31(9):1827-34. PubMed ID: 21734621
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Effect of Treatment of Idiopathic Intracranial Hypertension on Prevalence of Retinal and Choroidal Folds.
    Kupersmith MJ; Sibony PA; Feldon SE; Wang JK; Garvin M; Kardon R;
    Am J Ophthalmol; 2017 Apr; 176():77-86. PubMed ID: 28040526
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Intravitreal bevacizumab and ranibizumab injections for patients with polypoidal choroidal vasculopathy.
    Cho HJ; Kim JW; Lee DW; Cho SW; Kim CG
    Eye (Lond); 2012 Mar; 26(3):426-33. PubMed ID: 22173075
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Relationship between clinical characteristics of polypoidal choroidal vasculopathy and choroidal vascular hyperpermeability.
    Koizumi H; Yamagishi T; Yamazaki T; Kinoshita S
    Am J Ophthalmol; 2013 Feb; 155(2):305-313.e1. PubMed ID: 23022162
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Bevacizumab for serous changes originating from a persistent branching vascular network following photodynamic therapy for polypoidal choroidal vasculopathy.
    Kim KS; Lee WK
    Jpn J Ophthalmol; 2011 Jul; 55(4):370-377. PubMed ID: 21647565
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Unilateral papilledema in pseudotumor cerebri.
    Brosh K; Strassman I
    Semin Ophthalmol; 2013 Jul; 28(4):242-3. PubMed ID: 23627435
    [TBL] [Abstract][Full Text] [Related]  

  • 34. ONE-YEAR RESULTS OF INTRAVITREAL AFLIBERCEPT FOR POLYPOIDAL CHOROIDAL VASCULOPATHY.
    Hara C; Sawa M; Sayanagi K; Nishida K
    Retina; 2016 Jan; 36(1):37-45. PubMed ID: 26383709
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Reduced-fluence photodynamic therapy combined with intravitreal bevacizumab for polypoidal choroidal vasculopathy.
    Sagong M; Lim S; Chang W
    Am J Ophthalmol; 2012 May; 153(5):873-882.e2. PubMed ID: 22265146
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Comparison of intravitreal ziv-aflibercept and bevacizumab monotherapy in treatment-naive polypoidal choroidal vasculopathy.
    Singh SR; Sahoo NK; Goud NR; Chhablani J
    Indian J Ophthalmol; 2019 Jul; 67(7):1114-1118. PubMed ID: 31238423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Chorioretinal abnormalities in idiopathic intracranial hypertension: case reports.
    Ariello LE; Mello LGM; Pimentel SLG; Monteiro MLR
    Int J Retina Vitreous; 2022 Jul; 8(1):48. PubMed ID: 35869502
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Two-year results of a treat-and-extend regimen with aflibercept for polypoidal choroidal vasculopathy.
    Morimoto M; Matsumoto H; Mimura K; Akiyama H
    Graefes Arch Clin Exp Ophthalmol; 2017 Oct; 255(10):1891-1897. PubMed ID: 28669041
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Combined intravitreal ranibizumab and photodynamic therapy for polypoidal choroidal vasculopathy.
    Saito M; Iida T; Kano M
    Retina; 2012 Jul; 32(7):1272-9. PubMed ID: 22547209
    [TBL] [Abstract][Full Text] [Related]  

  • 40. THE OCCURRENCE, CHARACTERISTICS, MANAGEMENT, AND PROGNOSIS OF RETINAL PIGMENT EPITHELIUM TEARS IN PATIENTS WITH POLYPOIDAL CHOROIDAL VASCULOPATHY: A Retrospective Study of 397 Patients.
    Zhao XY; Xia S; Luo MY; Wang EQ; Chen YX
    Retina; 2020 Mar; 40(3):477-489. PubMed ID: 30475788
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.